hERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes
journal contribution
posted on 2015-10-12, 11:43 authored by J. C. Hancox, D. Melgari, C. E. Dempsey, Kieran E. Brack, John Mitcheson, G. André NghERG potassium channel inhibition by ivabradine may contribute to QT prolongation and risk of torsades de pointes
History
Citation
Therapeutic Advances in Drug Safety, 2015, 6 (4), pp. 177-179Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cardiovascular SciencesVersion
- AM (Accepted Manuscript)
Published in
Therapeutic Advances in Drug SafetyPublisher
SAGE Publicationsissn
2042-0986Copyright date
2015Available date
2015-10-12Publisher DOI
Publisher version
http://taw.sagepub.com/content/6/4/177Notes
Deposited with reference to the publisher's Green Open Access policy, available at https://uk.sagepub.com/en-gb/eur/the-green-route-â-open-access-archiving-policyLanguage
enAdministrator link
Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC